1. What's New on Interventions for Lower Limb Spasticity?

3. Program Goals

4. Disclaimers

5. Why Focus on Lower Limb Spasticity?

6. Approved Botulinum Toxins

7. AAN Guidelines on BoNT for Lower Limb Spasticity: 2008 Review

8. AAN Guidelines on BoNT for Lower Limb Spasticity: 2015 Update

9. AAN Guidelines on BoNT for Lower Limb Spasticity: Clinical Issues

10. Emerging Data: OnabotulinumtoxinA in the Lower Extremity – Study Design

11. Emerging Data: OnabotulinumtoxinA in the Lower Extremity – Results

12. More About GAS

13. On the Horizon: A2NTX

14. Update on Intrathecal Baclofen

15. Challenges of Intrathecal Baclofen

16. The Challenge: Assessing Functional Gain

17. Emerging Oral Therapy for Functional Gain

18. Emerging Oral Therapy for Functional Gain (cont)

19. A Closer Look at Outcome Measures

20. Summary and Key Points

21. References

22. References (cont)

23. References (cont)

24. Abbreviations